NSE shareholding pattern
Akums Drugs and Pharmaceuticals Limited shareholding pattern
As of the Jun 2026 shareholding pattern, filed 2026-06-30, promoters held 75.26%, FIIs 1.91%, and DIIs 13.44% of Akums Drugs and Pharmaceuticals Limited (AKUMS). Against the Mar 2026 pattern, FII holding is up 0.53 percentage points (1.38% → 1.91%), DII down 0.92 points (14.36% → 13.44%), and promoter holding unchanged at 75.26%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Akums Drugs and Pharmaceuticals Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 75.26 | 1.91 | 13.44 | 9.39 | 2026-06-30 |
| Mar 2026 | 75.26 | 1.38 | 14.36 | 9 | 2026-03-31 |
| Dec 2025 | 75.26 | 1.14 | 14.41 | 9.19 | 2025-12-31 |
| Sep 2025 | 75.26 | 2.27 | 9.28 | 13.19 | 2025-09-30 |
| Jun 2025 | 75.26 | 4.24 | 8.85 | 11.65 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Akums Drugs and Pharmaceuticals Limited
3 fund managers3 fund managers disclosed positions in Akums Drugs and Pharmaceuticals Limited within the same window (Apr 19, 2026 – Jul 18, 2026), per AMFI mutual-fund portfolios. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Akums Drugs and Pharmaceuticals Limited?
As of the Jun 2026 shareholding pattern, promoters held 75.26% of Akums Drugs and Pharmaceuticals Limited (AKUMS). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Akums Drugs and Pharmaceuticals Limited?
Foreign institutional investors held 1.91% of Akums Drugs and Pharmaceuticals Limited as of the Jun 2026 pattern, versus 1.38% in the Mar 2026 pattern. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How much did FII holding in Akums Drugs and Pharmaceuticals Limited change in the Jun 2026 quarter?
FII holding in Akums Drugs and Pharmaceuticals Limited was 1.38% in the Mar 2026 pattern and 1.91% in Jun 2026, a difference of 0.53 percentage points up. Promoter holding was unchanged at 75.26% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.